€24.08
0.35% yesterday
Xetra, Mar 21, 05:35 pm CET
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Bayer Stock price

€24.08
+2.03 9.21% 1M
-4.51 15.76% 6M
+4.77 24.68% YTD
-2.40 9.06% 1Y
-34.58 58.95% 3Y
-23.42 49.31% 5Y
-117.07 82.94% 10Y
Xetra, Closing price Fri, Mar 21 2025
+0.09 0.35%
ISIN
DE000BAY0017
Symbol
BAYN
Sector
Industry

Key metrics

Market capitalization €23.66b
Enterprise Value €56.44b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 18.17
EV/Sales (TTM) EV/Sales 1.21
P/S ratio (TTM) P/S ratio 0.51
P/B ratio (TTM) P/B ratio 0.74
Dividend yield 0.46%
Last dividend (FY24) €0.11
Revenue growth (TTM) Revenue growth -2.16%
Revenue (TTM) Revenue €46.61b
EBIT (operating result TTM) EBIT €4.52b
Free Cash Flow (TTM) Free Cash Flow €3.11b
Cash position €8.09b
EPS (TTM) EPS €-2.60
P/E forward 11.20
P/S forward 0.51
EV/Sales forward 1.22
Show more

Create a Free Account to create an Bayer alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Bayer Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Bayer forecast:

5x Buy
25%
15x Hold
75%

Analyst Opinions

20 Analysts have issued a Bayer forecast:

Buy
25%
Hold
75%

Financial data from Bayer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
46,606 46,606
2% 2%
100%
- Direct Costs 21,270 21,270
8% 8%
46%
25,336 25,336
9% 9%
54%
- Selling and Administrative Expenses 10,561 10,561
2% 2%
23%
- Research and Development Expense 6,209 6,209
16% 16%
13%
8,566 8,566
29% 29%
18%
- Depreciation and Amortization 4,050 4,050
3% 3%
9%
EBIT (Operating Income) EBIT 4,516 4,516
45% 45%
10%
Net Profit -2,552 -2,552
13% 13%
-5%

In millions EUR.

Don't miss a Thing! We will send you all news about Bayer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bayer Stock News

Negative
Reuters
about one hour ago
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said late on Friday.
Negative
Seeking Alpha
2 days ago
Bayer's stock surged 24.5% since December 2024, yet remains a speculative investment due to significant risks like high debt and ongoing litigation. 2024 annual results showed a 2.2% sales decline, with only free cash flow improving significantly; Pharmaceuticals saw slight growth, while Crop Science and Consumer Health declined. Bayer's 2025 outlook is uncertain, with potential sales growth of...
Negative
Reuters
4 days ago
Widely used prescription medicines could get caught up in the Trump administration's tariff trade wars and EU retaliation.
More Bayer News

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Head office Germany
CEO William Anderson
Employees 92,815
Founded 1863
Website www.bayer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today